LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

HomeStock ListAstraZeneca PLC ADR

AstraZeneca PLC ADR

Closed

68.9 -0.76

Overview

Share price change

24h

Current

Min

68.59

Max

69.75

Recommendations

By TipRanks

Rating Consensus

StrongBuy

12 Months Forecast

+16.87 upside

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

AstraZeneca PLC ADR chart

Related News

19 Mar 2024, 13:58 UTC

Acquisitions, Mergers, TakeOvers

Trending: Astrazeneca Aims to Accelerate Cancer Treatment Development With $2.4 Billion Fusion Deal

19 Mar 2024, 10:18 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Fusion Pharmaceuticals Shares Soar Premarket on AstraZeneca Deal

19 Mar 2024, 07:58 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Buys Fusion for Up to $2.4 Billion -- Update

19 Mar 2024, 07:23 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Buys Fusion for Initial $2 Billion

14 Mar 2024, 10:22 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca to Buy Rare-Disease Specialist Amolyt Pharma for Up to $1.05 Billion -- Update

14 Mar 2024, 07:32 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca to Buy Amolyt Pharma for Up to $1.05 Billion

11 Apr 2024, 09:12 UTC

Market Talk

AstraZeneca's CEO Pay Raises Compensation Questions Across Sector -- Market Talk

19 Mar 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Fusion Rockets 97%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover -- IBD

19 Mar 2024, 15:18 UTC

Market Talk
Acquisitions, Mergers, TakeOvers

No Competing Bids Seen For Fusion Pharma -- Market Talk

19 Mar 2024, 15:00 UTC

Acquisitions, Mergers, TakeOvers

Fusion Rockets 97%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover -- IBD

19 Mar 2024, 13:03 UTC

Acquisitions, Mergers, TakeOvers

Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover -- IBD

19 Mar 2024, 11:21 UTC

Acquisitions, Mergers, TakeOvers

Fusion Pharmaceuticals Is Being Acquired by AstraZeneca in $2.4 Billion Deal. The Stock Is Soaring. -- Barrons.com

19 Mar 2024, 11:00 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca To Acquire Fusion To Accelerate The Development Of Next-generation Radioconjugates To Treat Cancer >AZN

19 Mar 2024, 09:33 UTC

Hot Stocks

Stocks to Watch Tuesday: Unilever, Fusion Pharmaceuticals, Tesla -- WSJ

19 Mar 2024, 07:43 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Buys Fusion for Up to $2.4 Bln -- Update

19 Mar 2024, 07:08 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Buys Fusion for Initial $2 Bln

19 Mar 2024, 07:03 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: Initial Sum Values Fusion at $2bn

19 Mar 2024, 07:02 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Buying Fusion for $21.00 a Shr, Plus Contingent Value Right of $3.00

19 Mar 2024, 07:01 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Buying Fusion to Accelerate Development of Next-Generation Radioconjugates to Treat Cancer

19 Mar 2024, 07:00 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca to Buy Fusion

14 Mar 2024, 10:07 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca to Buy Rare-Disease Specialist Amolyt Pharma for Up to $1.05 Bln -- Update

14 Mar 2024, 07:17 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca to Buy Amolyt Pharma for Up to $1.05 Bln

14 Mar 2024, 07:03 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: Transaction Is Expected to Close by the End of the 3Q of 2024

14 Mar 2024, 07:03 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: To Buy All Shares of Amolyt Pharma For Up to $1.05B

14 Mar 2024, 07:01 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: Amolyt's Development Portfolio Includes Phase III Asset Related to Chronic Hypoparathyroidism

14 Mar 2024, 07:00 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca PLC to Buy Amolyt

22 Feb 2024, 13:19 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: Deal Was Announced in December 2023

22 Feb 2024, 13:17 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: Acquisition Boosts Pipeline of Cell Therapy

22 Feb 2024, 13:16 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca: Gracell Biotechnologies Inc. is a Clinical-Stage Biopharmaceutical Developing Treatment of Cancer and Autoimmune Diseases

22 Feb 2024, 13:15 UTC

Acquisitions, Mergers, TakeOvers

AstraZeneca Completes Acquisition of Gracell

Peer Comparison

Price change

AstraZeneca PLC ADR forecast

Price Target

By TipRanks

16.87% upside

12 Months Forecast

Average 80.56 USD  16.87%

High 86 USD

Low 75 USD

Based on 8 Wall Street analysts offering 12 month price targets for AstraZeneca PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

StrongBuy

8 ratings

6

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

67.25 / 68.99 Support&Resistance

Short Team

Very Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence